Inhaled Medications used in Respiratory Disease Donna Turner, BSc, RRT, CRE Community Respiratory Care Program, Cooperative Health Centre, Prince Albert
A presentation on inhaled medication devices new and old. What to consider ensuring maximal drug delivery to your patients and how help choose the best device for each patient. Will also show resources available for clinicians to use in their practice.
This presentation is designed to promote correct inhaler techniques for people who suffer from asthma outlining what asthma is, the symptoms, how to use different inhalers. To find out more check out our blog section on inhaler techniques
https://www.nationwidepharmacies.co.uk/nwp-news/inhaler-technique/
This presentation is designed to promote correct inhaler techniques for people who suffer from asthma outlining what asthma is, the symptoms, how to use different inhalers. To find out more check out our blog section on inhaler techniques
https://www.nationwidepharmacies.co.uk/nwp-news/inhaler-technique/
Bronchial Thermoplasty (BT) Novel Treatment for Patients with Severe AsthmaBassel Ericsoussi, MD
Do our Asthma Patients Know What They Are Missing?Now, A Revolutionary Procedure Can Help Them Lead A Fuller Life.
Bronchial Thermoplasty (BT) Novel Treatment For Patients With Severe Asthma
by
Dr. Khairul Hassan Jessy
MD (Chest Diseases)
Associate Professor, Respiratory Medicine
National Institute of Diseases of the Chest and Hospital (NIDCH)
Mohakhali, Dhaka.
Bronchial Thermoplasty (BT) Novel Treatment for Patients with Severe AsthmaBassel Ericsoussi, MD
Do our Asthma Patients Know What They Are Missing?Now, A Revolutionary Procedure Can Help Them Lead A Fuller Life.
Bronchial Thermoplasty (BT) Novel Treatment For Patients With Severe Asthma
by
Dr. Khairul Hassan Jessy
MD (Chest Diseases)
Associate Professor, Respiratory Medicine
National Institute of Diseases of the Chest and Hospital (NIDCH)
Mohakhali, Dhaka.
The IOSR Journal of Pharmacy (IOSRPHR) is an open access online & offline peer reviewed international journal, which publishes innovative research papers, reviews, mini-reviews, short communications and notes dealing with Pharmaceutical Sciences( Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy & Phytochemistry, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest........more details on Aim & Scope).
All manuscripts are subject to rapid peer review. Those of high quality (not previously published and not under consideration for publication in another journal) will be published without delay.
A Guide to Aerosol Delivery Devices for Respiratory TherapistsUtai Sukviwatsirikul
A Guide to Aerosol Delivery Devices for Respiratory Therapists,
3rd Edition American Association for Respiratory Care
http://www.irccouncil.org/newsite/members/aerosol_guide_rt.pdf
Inadequate management of asthma can lead to physical handicap and death. The study aimedto assess knowledge and practice of
asthmatic participants for use meter dose inhaler device. A descriptive study involved 105 participants, conducted at public
hospitals in Khartoum state from July to October2014. Questionnaire and observational check list were used for data collection.
The study enrolled (51%) female and (49%) male. Most of participants their age group ranged, between 36 to 45 years, (35%)
were workers and (31%) received University education while 44 % had a chronic asthma. Level of participant’s knowledge was a
very good regard care and storage of the device; sequent (77% - 79%). There were(64%) had moderate level of knowledge for
preparation dose (69%) replacing inhaler device and cleaning mouthpiece (60%), while 56% had very poor knowledge to rinse
mouth after puff. A highly significant difference between the level of knowledge and education (P value<0.001) regard replacing
the inhaler device, and cleansing mouthpiece. All participants demonstrated correct technique of using inhaler device, position,
removed, pressed replacement the cap, shaking inhaler device and took deep breath. While half of them had moderate skill level
for opened mouth technique, continuous breathing and rinsed mouth after puffuse, and fewer of participants had poor technique
during repeating the puff. Most of participants reflected moderate to poor level of knowledge and have very good practice for
correct used inhaler meter device; this reveals the discrepancy between knowledge and practice.
A Little Bit of Everything, Quick & Snappy: Probiotics to Advances in the Car...PASaskatchewan
As pharmacists, you are rarely faced with a consistent patient population with similar problems and questions. More likely, each patient you interact with has unique and varied concerns that you must be ready to address in an instant. This session reflects the diversity of patients a pharmacist will face in day-to-day practice and covers a range of topics in a quick and snappy format. This session will cover the evidence as it relates to concurrent probiotic and antibiotic use, second line treatment for patients with type 2 diabetes, and explore new utilization strategies of using drugs traditionally used in the treatment of type 2 diabetes for patients with type 1 diabetes.
Pharmacists will soon be able to offer comprehensive travel consultations including prescribing travel-related vaccines. This session will serve as an introduction to the topic by taking you through the most common questions faced in community pharmacy.
Preventing Opioid Overdose Deaths with Take-home Naloxone/ NIHB PolicyPASaskatchewan
An overview of Take Home Naloxone including who should be counselled, some counselling tips and most importantly how to recognize and respond to an opioid overdose using Naloxone. We will finish off the discussion with Non-Insured Health Benefits (NIHB) coverage and where to go when you have questions or difficulties in obtaining drug coverage for your patients.
This session will help pharmacists enhance their expertise in managing patients with hypertension through updates on the latest hypertension guidelines, discussion on the role that pharmacists can and should play in the detection and ongoing management of hypertension and hands-on experience with blood pressure measurement devices.
Saskatchewan Transfer Discharge Medication Reconciliation Form OverviewPASaskatchewan
A discussion of the provincial transfer/discharge medication reconciliation form from acute care facilities. We will discuss the form in the current state and the purpose of the form when presented to community pharmacies across the province. This discussion will help gain an understanding of the patients “story” of medications utilized prior to admission to hospital, what medications were utilized in hospital and what medications the patient is to continue after discharge. The session will help community pharmacists understand what medications are to be dispensed from the form. The understanding of the use of the form will allow community pharmacies to provide a continuity of care of the patient in the transition from an acute care facility to their community home.
A review of pharmacist-led transition of care systems, specifically post-discharge follow-up phone calls, and the opportunity for pharmacy students to lead a new service. A review of the “Post-Discharge Follow-up Phone Call SPEP Standard Work” project will be provided, including an overview of the methodology, results, and discussion.
Pharmacists will soon be able to offer comprehensive travel consultations including prescribing travel-related vaccines. This session will serve as an introduction to the topic by taking you through the most common questions faced in community pharmacy.
Medicine Plants- Medicinal Ceremony - Elder Betty McKenna, Instructor FNU of Canada
Session touches on the importance of medicine plants and medicinal ceremony in the indigenous practice of Medicine wheel wellness.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
3. Disclosures
Astra Zeneca
Glaxo SmithKline
Boehringer Ingelheim
Novartis
U of S College of Nursing
U of S College of Medicine
Palliative Care Association-Prince Albert Division
SIAST LPN program
Lung Association of Saskatchewan
Saskatchewan College of Respiratory Therapists
4. Outline
Understand factors involved in therapeutic
effectiveness of inhaled medications.
Factors involved in determining the right
device for each patient.
How to educate patients on the proper use
of devices.
5. All inhalers are NOT created equal
When inhalers are used correctly, there is little
difference in clinical efficacy between different inhaler
types
Patients are not created equal and this is the only limit
of these devices, one inhaler does not fit all.
New inhaler devices - the good, the bad and the ugly.
Lavorini F, et al. Respiration 2014;88:3–15
6. Factors affecting therapeutic
effectiveness of inhaled meds
Particle size of delivered med
Resistance within dry powder devices
Inspiratory flow by patient
Coordination of activation of device and inhalation
Correct inhaler use
7. Particle size and its importance
http://www.slideshare.net/ashrafeladawy/asthma-inhaler-techniques
8. Inspiratory resistance in DPIs
Low resistance devices
Breezhaler
Medium resistance devices
Ellipta/Genuair/Diskus
High resistance devices
Turbuhaler/Handihaler
Dry powder inhalers and the right things to remember: a concept review
Dal Negro,R. Multidisciplinary Respiratory Medicine (2015) 10:13
10. Coordination of inhalation and activation
MDI vs SMI vs DPI
DPI are breath actuated, so timing of inhalation is not
an issue and some are pre loaded for easier use.
MDI and SMI require coordination of timing of
inhalation with activation of delivery of med
Some inhalers have numerous steps involved in the
delivery of inhaled med and this can lead to missteps in
the procedure
11. What is the right device?
Base this on:
Ability of pt to coordinate device optimally
Ability to reach peak inspiratory flow for device
Physical Limitations
Arthritis
Tremor
Poor Eyesight
Consider possible poor medication delivery during acute
“attacks”
Advancing disease
Allowing pts to handle different devices and have a choice
Does the pt feel the med is working?
12. Checking device use and education
Evaluation of the use of inhaled medications by hospital inpatients with chronic obstructive pulmonary disease.
Batterink J, et al. Can J Hosp Pharm. 2012.
28. References
1.Evaluation of the use of inhaled medications by hospital inpatients with chronic
obstructive pulmonary disease.J, et al. Can J Hosp Pharm. 2012.
2.Rx Files –COPD New Drugs, New Devices and Considerations for Best Practice Sept/15
3. The Science of Respiratory Medication Delivery Information taken from a
2014Webinar presentation by Dr. Janice Leung, MD
4.New inhaler devices - the good, the bad and the ugly.Lavorini F, et al. Respiration
2014;88:3–15
5.Inhaler Technique and Training in People With Chronic Obstructive Pulmonary
Disease and Asthma:Choosing the Correct Inhaler
Toby G.D. Capstick, MRPharmS; Ian J. Clifton, MD Medscape CME Released: 01/27/2012
6.Dry powder inhalers and the right things to remember: a concept review
Dal Negro,R. Multidisciplinary Respiratory Medicine (2015) 10:13
7.Not all asthma inhalers are the same: factors to consider when prescribing an
inhaler Henry Chrystyna , David Pricea. Primary Care Respiratory Journal (2009)
8. http://www.specialconnections.ku.edu/?q=instruction/direct_instruction
9.Lung Association of Saskachewan-Inhaler videos and inhaler instruction sheets
10. Inhalation device requirements for patients' inhalation maneuvers PeterHaidl,et al
Hi, my name is Donna Turner… I want to Thank you for inviting me to speak today about Inhaled medications used in Respiratory disease.
I want to start by acknowledging all the mom’s in the audience today and wish you all a very happy Mother’s day!
I am a Respiratory Therapist and Certified Respiratory Educator and I have worked in Prince Albert for 32 years –some acute care, home care and now in a primary care clinic.
I taught the RespTrec programs for the Lung Ass.of Saskatchewan for13 years but have been a volunteer with the Lung Association since I moved to Prince Albert, supporting the Pink Panters COPD program back in the early 1990s.
So now I am working at the Cooperative Health Centre Community clinic in Prince Albert where there are 2 Respiratory Therapist CREs and we provide spirometry and education to asthma and COPD patients along with providing evaluations to help diagnose patients with chronic cough, shortness of breath and other respiratory issues.
We see approximately 1500 patients per year so we get lots of practice teaching people about their inhaled medications and see a lot of the gaps in good drug delivery to the lungs.
I am passionate about Respiratory care and Respiratory health and always looking for new ways to improve people’s breathing!
All devices have their own particular engineering principles for proper medication delivery.
BUT…there are basic principles of how drugs are delivered to lungs you need to be aware of.
Particles of medication need to get past the upper oropharynx then moving down to the diseased portions of the lung near the terminal bronchioles and alveoli.
Proper size is in the 1-5um size. Too big, they deposit too high in the oropharynx and larger airways, too small and they are exhaled out.
Increased risk of s.e. if there is deposit at the back of the throat and upper airway.
DPIs are breath actuated-need a deep and forcible inhalation at the start of the inhalation to deliver the proper size particles. The dry powder inhalers are designed in such a way that the drug/carrier mixture is partly deagglomerated into inhalable drug particles by the inspiratory airflow of the patient. The extent of device emptying and deagglomeration, depends strongly on the inspiratory airflow and absolute lung capacity, both of which differ from patient to patient and which determines the fine particle dose of drug emitted from the dry powder inhaler.
MDIs produce consistent, appropriate particle size on activation carried in a propellant.
Respimat SMI produce fine mist of the proper size particles on activation without a propellant.
No significant resistance with the MDI or SMI devices
We need to know there is a resistance within a device and how this relates to the inspiratory flow required by the patient to disperse the drug into the appropriate particle size to then be inhaled into the diseased area of the lung.
For DPIs additional effort is necessary to overcome the device specific resistance to reach the required flow rate.
Low resistance device requires high flow rate to disperse drug-the resistance within the device is not helping with this maneuver.
Medium resistance device requires moderate force to produce the required inspiratory flow rate. The resistance of the device is involved in breaking up the particles within device and then pt completes inhalation of med.
High resistance device requires a significantly higher force to produce the required inspiratory flow rate.The resistance of the device is involved in breaking up the particles within device and then pt completes inhalation of med.
The extent of device emptying and deagglomeration, which determines the fine particle dose of drug emitted from the dry powder inhaler, depends strongly on the inspiratory airflow and absolute lung capacity, both of which differ from patient to patient.
MDI flow rate-less than 90 lpm. Slow and steady with breath hold at the end of inhalation. Too fast, too turbulent, less drug delivery. Spacer improves delivery.
SMI flow rate-not dependent on the pt’s insp flow . Slow deep breath with a 10 second breath hold being ideal.
Every breath-actuated DPI has a minimum threshold in terms of flow efficiency. If the inspiratory flow rate is too low (or the flow acceleration below a threshold), deagglomeration is insufficient and a reduced dose is delivered
The limits of the DPIs in advanced disease is that all these devices require a fast deep inspiration and some pts cannot generate sufficient insp flow with DPIs. Not all COPD patients but some with advanced COPD pts have inadequate PIF which may limit use of some or all DPIs.
Plugging the nose may allow a greater inspiratory flow through mouth.
One of our patients was not able to generate the high inspiratory flow required for the Breezhaler device. He actually cut the end off of each capsule for his Breezhaler and dumped the med into the chamber so he could get the med out of the device! Snorting Onbrez! New drug deliver method?
Advantage of DPI over MDI and SMI is that they are breath actuated and for some pre loaded. This is very appealing to some patients.
Remember, just because you have severe COPD does not mean you will not be able to use DPIs.
Using the IN Check dial for checking inspiratory flow of pts using DPI and to emphasize the slower inspiration required with the MDIs.
What do we do with patients to know what inhaler will work or what they have won’t work?
What tools?
What signs?
IN check dial helps determine inspiratory strength of patients against various resistances similar to the resistances of inhalers.
Basically, if a pt cannot inspire strong enough for one type of inhaler, then we need to move to alternate device
Eg:Pt could not turn the Respimat device due to her arthritis.
Recent study in Vancouver found 59% of patients admitted to hospital for COPD AE misused their inhalation devices. 93% of those using an MDI made at least one critical error contributing to inadequate amts of drug delivered to lungs.
Correct use of the inhalation devices will maximize the beneficial effects of therapy, while minimizing potential adverse effects.
Identification of poor inhaler technique is an integral part of the management of patients with asthma or COPD
Provision of appropriate training is going to remain essential for the management of patients with asthma and COPD for the foreseeable future.
Regular review of watching patients taking their inhaled medication is also important.
Ideally if we all use the same instructions to teach proper inhaler use then the message gets across to our patients.
These are just a few of the education tools available from the Lung Association of Saskatchewan.
Videos are also available on line to direct your patients to when time is an issue.
While educating someone on a new inhaler, sometimes it’s good to know some of the things that could go wrong and we can emphasize these points to ensure mastery!
MDI
No appreciable resistance
Requires coordination of actuation and inhalation
Med is delivered with a propellant.
Can add spacer to improve drug delivery
Needs slow deep inspiration with breath hold at the end of inspiration-breath in should be 3-5 sec long.
Make sure they know how to check that if it is empty-count doses used per day or listen for med in canister or weight of canister helps indicate doses left.
Discus
Medium resistance device.
Pre-loaded with med.
Can double dose this device-if opened but no med inhaled, when you open again, the last dose is still there, added to the second dose.
Pt must keep this device level once loaded because dose will fall from device if tipped.
Make sure they understand to open lid, then open device.
Turbuhaler
High resistance dry powder device.
Preloaded with medication.
Need to hear the click after you turn one way then back to indicate drug is loaded.
Requires a very strong deep inspiration to deliver med.
Cannot double dose, will not load one dose on top of another if first dose not inhaled.
When you shake device the drying agent is what you hear not the med.
Med counter can be hard to see until it gets to last 20 doses, then red wheel appears.
Red trainer is not indicating pt has enough inspiratory strength
Handihaler
High resistance capsule-based device.
Requires a strong deep inspiration to deliver med.
Requires insertion of med pill-watch for pt taking pill orally or rectally!
Pt with issues with eyesight may struggle to see where to put capsule.
Medication sensitive to light and temperature, keep in foil packaging until ready to use.
Pt with tremors will have difficulty loading this med.
Capsule is opaque and cannot see when capsule is empty-patients sometimes take it apart to see if it is empty!
Pt needs to take 2 inhalations to make sure they empty capsule adequately.
Some patients cannot draw the medication deep enough for effect.
Make sure pt releases button on sides after puncturing capsule.
Pt needs to wash hands after use.
TTwisthaler
High resistance dry powder device.
Preloaded with medication.
When pt takes off the lid, the med is loaded and ready to take.
Pt has to tighten the lid down tight to make sure next dose is loaded.
Pt needs to watch the number of doses decrease when they open device
Requires a very strong deep inspiration to deliver med.
Med counter easy to see and device locks out when the device is empty.
Breezhaler.
Low resistance capsule-based device.
Require insertion of med pill-watch for pt taking pill orally or rectally!
Medication sensitive to light and temperature, keep in foil packaging until ready to use.
Pt with tremors will have difficulty with this med.
Pt with issues with eyesight may struggle to see where to put capsule.
Capsule is clear so easy to see if empty after taking dose.
Fast inspiratory flow is required to deliver meds deep within lungs with this device which may be difficult for some patients
Make sure pt releases buttons on sides after puncturing capsule.
Static on pill can make it difficult to puncture pill-can puncture pill when device is open then close device and inhale
Ellipta
Medium resistance device.
Preloaded with med.
Device requires a fast inspiratory flow.
Make sure they hear the click when they open the device fully
Pt must not cover air vents on top of inhaler as this helps maximize inspiratory flow and subsequent drug delivery.
Big numbers on the front make it easy to see.
Easy to open for patients with arthritis or little hands.
Must not blow into device or med will come out the air vents.
Cannot double dose as it dumps one dose before another is loaded.
Must keep unit level when opened to prevent dumping out dose.
Genuair
Medium resistance device.
Pre loaded with med.
Has acoustic and auditory signals to help pts know they have taken the inhaler properly.
Taste can be a deterrent to use.
The Genuair® locks after the last dose.
Twice per day dosing may lead to non-adherence to schedule.
Respimat
Device delivers fine particles in a soft mist with no appreciable resistance
Needs coordination of inhalation and drug delivery from device.
Cannot use with Spacer to help with coordination until further studies.
Close lips tightly around the mouthpiece without closing the air vents (on the sides of the mouthpiece)
The high amount of fine particles exit device slower and for a longer period of time(1.5s) compared to the MDI.
Higher lung deposition, no propellant.
10 secs breath hold required to improve drug delivery.
Requires assembly prior to using device for the first time
Needs priming to start or if not used for 30 days.
When the arrow reaches the end of the scale the inhaler locks automatically.
Teamwork really is how we improve our chances of success…..find the resources in your area who can help!